Edwards Lifesciences (EW) Work In Process (2010 - 2026)

Edwards Lifesciences' Work In Process history runs 13 years deep, the most recent figure standing at $242.2 million for Q1 2026.

• In Q1 2026, Work In Process fell 6.92% year-over-year to $242.2 million; the TTM figure through Mar 2026 stood at $242.2 million (down 6.92% YoY), while the FY2025 annual figure was $252.9 million, up 7.07% from the prior year.
• Work In Process was $242.2 million for Q1 2026 at Edwards Lifesciences, down from $252.9 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $275.9 million in Q3 2025 to a low of $195.8 million in Q4 2023.
• Historically, Work In Process has averaged $246.5 million across 4 years, with a median of $248.6 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Work In Process gained 20.63% in 2024, then slipped 6.92% in 2026.
• A 4-year view of Work In Process shows it stood at $195.8 million in 2023, then advanced by 20.63% to $236.2 million in 2024, then increased by 7.07% to $252.9 million in 2025, then retreated by 4.23% to $242.2 million in 2026.
• The last three Work In Process figures came in at $242.2 million (Q1 2026), $252.9 million (Q4 2025), and $275.9 million (Q3 2025), per Business Quant data.